Pharmaceuticals, Biotechnology and Life Sciences
– Total Revenues of $599 million for the Fourth Quarter of 2025, $2.320 billion for the Fiscal Year 2025 –…
Product Sales Excluding Veklury Increased 4% Year-Over-Year to $28.0 billion for Full Year 2025 Biktarvy Sales Increased 7% Year-Over-Year to…
GENTILLY, France–(BUSINESS WIRE)–THX Pharma (Theranexus) and Biocodex, an independent international pharmaceutical group, today announced the execution of a strategic licensing…
WILMINGTON, Del.–(BUSINESS WIRE)–#AOPHealthUS—AOP Health US, LLC has been awarded a Pharmaceutical national group purchasing agreement with Premier, Inc. Effective…
DALLAS–(BUSINESS WIRE)–Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging artificial intelligence to accelerate oncology drug discovery and development,…
The first and only cartridge-based FDA-cleared viscoelastic testing platform for obstetrics, the Quantra System provides comprehensive blood analysis, delivering rapid,…
PLYMOUTH MEETING, Pa.–(BUSINESS WIRE)–Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will report fourth quarter and full year…
─ Virtual Webinar on Tuesday, Feb. 17 at 3 p.m. ET / 12 p.m. PT ─ Will feature discussion and…
CINCINNATI–(BUSINESS WIRE)–CinRx Pharma, a multi-asset clinical development organization, today announced the appointment of Rez Halse, PhD, as President. Dr. Halse…
Financing round led by RA Capital Management Proceeds to support Phase 3 development of BPZE1 with pivotal study to begin…